InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
UTR | Ann: Half Yearly Report and Accounts | 28/03/19 | 31 | 9.3K | |||
|
|||||||
UTR | Ann: Response to Appendix 4C Query | 26/02/19 | 23 | 5.5K | |||
|
|||||||
UTR | Ann: December 2018 Quarterly Report & Appendix 4C | 21/02/19 | 120 | 23K | |||
|
|||||||
UTR | Ann: Results of Meeting | 31/01/19 | 259 | 54K | |||
|
|||||||
UTR | Ann: Ceasing to be a substantial holder | 13/01/19 | 6 | 3.1K | |||
|
|||||||
UTR | Ann: Appendix 3B | 09/01/19 | 0 | 464 | |||
|
|||||||
UTR | Ann: UTR raises $2.5M through oversubscribed share placement | 03/01/19 | 47 | 17K | |||
|
|||||||
UTR | Ann: Appendix 3B | 02/01/19 | 0 | 525 | |||
|
See All Discussions